Zeneca Group plc (NYSE ticker ZEN) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Zeneca Group plc (NYSE ticker ZEN)

ZEN 77.48

0.0%

Nov 21 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Anthony Wong who wrote (47)	10/29/1998 12:16:00 PM
From: DavesM	Read Replies (1) of 75

Found on the Yahoo Zen site: Vanderbilt University has used an experimental cancer med licensed to Zeneca to reverse paralysis in mice. The posting also has an article from cnn.com cnn.com I believe that this drug is also known as ZD101 and is phase II testing (antiangiogenisis for cancer).

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next